Increase/Decrease in Cash: The total change in cash for the company over the given period.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Increase/Decrease in Cash of $3.47M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-40.21M |
|
-- |
|
-- |
|
$48.72M |
|
$-48.72M |
|
$8.51M |
|
$-40.21M |
|
$-40.21M |
|
$-40.21M |
|
$-40.21M |
|
$-40.21M |
|
$-40.21M |
|
$-48.72M |
|
$-51.06M |
|
10.92M |
|
10.92M |
|
$-3.68 |
|
$-3.68 |
|
| Balance Sheet Financials | |
$152.98M |
|
$0.39M |
|
$2.90M |
|
$155.88M |
|
$11.82M |
|
-- |
|
$1.63M |
|
$13.45M |
|
$142.43M |
|
$142.43M |
|
$142.43M |
|
12.18M |
|
| Cash Flow Statement Financials | |
$-41.79M |
|
$-121.31M |
|
$166.58M |
|
$14.39M |
|
$17.87M |
|
|
Increase/Decrease in Cash |
$3.47M |
$6.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-41.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.23% |
|
-28.23% |
|
-25.80% |
|
-28.23% |
|
$11.69 |
|
$-3.83 |
|
$-3.83 |
|